Reuters logo
BRIEF-Oasmia Pharmaceutical says through rights issue, its share capital up by 5 mln SEK to 17.6 mln SEK
July 7, 2017 / 8:15 PM / 4 months ago

BRIEF-Oasmia Pharmaceutical says through rights issue, its share capital up by 5 mln SEK to 17.6 mln SEK

July 7 (Reuters) - Oasmia Pharmaceutical Ab

* Says through rights issue, Oasmia’s share capital increases by sek 5 million to sek 17.6 million

* New shares subscribed for by exercise of preferential rights are expected to be admitted to trading on nasdaq stockholm on July 27, 2017

* New shares subscribed for without preferential rights are expected to be admitted to trading around August 2, 2017

Source text for Eikon:

Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below